Page 4 - Peter Arlett News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter arlett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Arlett Today - Breaking & Trending Today

EU backs AZ vaccine as blood clot reviews continue

Updated / Friday, 23 Apr 2021
23:03
Several countries in the European Union and worldwide have limited the use of the vaccine
Europe s drug regulator has reiterated that the benefits of AstraZeneca s Covid-19 vaccine outweigh any risks, as part of a detailed guidance from ongoing reviews into rare blood clots to help individual nations determine the shot s use.
The renewed backing comes after several countries in the European Union and worldwide have limited the use of the vaccine, known as Vaxzevria, while Denmark has stopped its use altogether, after possible links to clotting issues were confirmed.
The interim analysis by a committee of the European Medicines Agency (EMA) determined that serious side effects of rare blood clots are likely to occur in 1 out of 100,000 vaccinated people, the regulator said in a statement. ....

Astrazeneca Covid , Peter Arlett , European Union , European Medicines Agency , ஐரோப்பிய தொழிற்சங்கம் ,

EMA Says AstraZeneca Vaccine Benefits Increase With Age

EMA Says AstraZeneca Vaccine Benefits Increase With Age
By Danny KEMP
04/23/21 AT 11:38 AM
The benefits of AstraZeneca s Covid-19 vaccine increase with age and still outweigh the risks for adults despite links to very rare blood clots, the EU s drug regulator said Friday.
Health authorities should also continue to give a second dose of the vaccine, dogged by controversy over the rare but occasionally fatal clots, the European Medicines Agency (EMA) said.
The Amsterdam-based EMA was presenting the findings of a review ordered by the European Commission after concerns that prompted several countries to restrict the AstraZeneca jab s use to older people. ....

Bruxelles Capitale , Noord Holland , Astrazeneca Covid , Peter Arlett , Noel Wathion , European Medicines Agency , European Commission , Executive Director Noel Wathion , ப்ரூக்ஸெல்ஸ் தலைநகரம் , நூற்த் ஹாலண்ட் , ஐரோப்பிய தரகு ,

EMA reiterates benefits of AstraZeneca Covid-19 vaccine outweigh any risks

EMA reiterates benefits of AstraZeneca Covid-19 vaccine outweigh any risks
Serious side effects of rare blood clots are likely to occur in 1 out of 100,000 vaccinated people, analysis finds
about 6 hours ago
Peter Arlett, head of EMA’s data analytics and methods task force, said: “The benefit risk balance of the AstraZeneca vaccine is positive. It’s preventing serious disease and saving lives.” Photograph: EPA

Europe’s drug regulator reiterated on Friday the benefits of AstraZeneca’s Covid-19 vaccine outweigh any risks, delivering an assessment based on continuing reviews into rare blood clots to help countries determine the shot’s use. ....

Astrazeneca Covid , Peter Arlett , European Medicines Agency , European Union ,

EMA re-iterates its view that the benefits of using the AstraZeneca vaccine outweigh the risks

EMA re-iterates its view that the benefits of using the AstraZeneca vaccine outweigh the risks
By Michael Carolan
The European Medicines Agency has released the findings of its interim assessment of the Astrazenca Covid vaccine.
It s re-iterated its view the benefits of using the vaccine outweigh the risks.
Head of Data Analytics at the EMA
Peter Arlett says the evidence is clear that the use of the vaccine prevents hospitalisations and deaths:

The Department of Health says it has been notified of 1 additional death related to COVID-19 today and 434 new cases.
Of the cases notified today:
228 are men / 204 are women ....

Astrazenca Covid , Peter Arlett , Department Of Health , European Medicines Agency , Data Analytics , துறை ஆஃப் ஆரோக்கியம் , தகவல்கள் பகுப்பாய்வு ,

'Benefits outweigh the risks': New data shows why European regulators back AstraZeneca jab

A medical worker prepares a dose of the AstraZeneca/Oxford University jab
Credit: Baz Ratner/Reuters
The AstraZeneca coronavirus vaccine provides a significant benefit in avoiding hospital admission across all age groups, the European Medicines Agency (EMA) has said.
Overall, the benefits of the jab continue to outweigh the risks of rare blood clots, and benefits increase in older age groups and in areas with higher levels of coronavirus infection, the regulator said.
The EMA said its human medicines committee (CHMP) had analysed available data on the vaccine to put the risk of rare blood clots into context of benefits for different age groups and different rates of infection. ....

United Kingdom , Peter Arlett , Paul Nuki Paulnuki , Noel Wathion , European Medicines Agency , Regulatory Agency , Paul Nuki , ஒன்றுபட்டது கிஂக்டம் , பால் னுகி ,